-+ 0.00%
-+ 0.00%
-+ 0.00%

Lantheus Q1 FY26 EPS climbs 76.5% to $1.80; revenue rises 1.2% to $377.3 million

PUBT·05/07/2026 11:12:28
Listen to the news
Lantheus Q1 FY26 EPS climbs 76.5% to $1.80; revenue rises 1.2% to $377.3 million
  • Lantheus reported Q1 worldwide revenue up 1.2% to $377.3 million; GAAP diluted EPS climbed 76.5% to $1.80.
  • GAAP net income rose 62.3% to $118.4 million; operating income fell 20.3% to $81.3 million.
  • PYLARIFY sales dropped 6.5% to $240.9 million, while DEFINITY sales increased 6.8% to $84.6 million.
  • FDA approved PYLARIFY TruVu, with phased geographic launch planned to begin in Q4 2026; FDA granted tentative approval for Lutetium Lu 177 Dotatate (PNT2003).
  • Full-year 2026 guidance reaffirmed for revenue of $1.4 billion-$1.45 billion; adjusted diluted EPS of $5.00-$5.25.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantheus Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605070700PRIMZONEFULLFEED9714990) on May 07, 2026, and is solely responsible for the information contained therein.